MidFirst Bank Acquires New Holdings in Corteva, Inc. $CTVA

MidFirst Bank bought a new position in Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 19,188 shares of the company’s stock, valued at approximately $1,625,000.

Other large investors have also added to or reduced their stakes in the company. JPL Wealth Management LLC bought a new position in shares of Corteva during the 3rd quarter valued at $25,000. Garton & Associates Financial Advisors LLC purchased a new position in shares of Corteva in the 4th quarter worth $27,000. Bank of Jackson Hole Trust bought a new stake in shares of Corteva in the fourth quarter worth $28,000. Cornerstone Financial Management LLC purchased a new stake in Corteva during the fourth quarter valued at $29,000. Finally, Elevation Wealth Partners LLC increased its position in Corteva by 334.6% during the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after acquiring an additional 261 shares during the last quarter. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

NYSE:CTVA opened at $75.73 on Tuesday. The stock has a 50-day simple moving average of $81.78 and a two-hundred day simple moving average of $80.09. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $90.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The firm has a market capitalization of $50.53 billion, a PE ratio of 50.15, a P/E/G ratio of 2.35 and a beta of 0.57.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter in the prior year, the business posted $2.20 earnings per share. The business’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 1.0%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Bank of America raised their target price on Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Rothschild & Co Redburn upped their price target on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Royal Bank Of Canada increased their price objective on shares of Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 21st. Wells Fargo & Company raised their price objective on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Finally, Citigroup boosted their target price on shares of Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $91.70.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.